Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing
出版年份 2022 全文链接
标题
Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing
作者
关键词
-
出版物
Alzheimers & Dementia
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-02-26
DOI
10.1002/alz.12620
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Bringing Alzheimer Disease Testing and Results Disclosure Into the 21st Century Cures Act
- (2022) Emily A. Largent et al. JAMA Neurology
- The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
- (2021) Joel Simrén et al. Alzheimers & Dementia
- Why Inclusion Matters for Alzheimer’s Disease Biomarker Discovery in Plasma
- (2021) Mostafa J. Khan et al. JOURNAL OF ALZHEIMERS DISEASE
- The Future Is P-Tau—Anticipating Direct-to-Consumer Alzheimer Disease Blood Tests
- (2021) Emily A. Largent et al. JAMA Neurology
- Virtual disclosure of preclinical Alzheimer's biomarkers: Preliminary experiences
- (2021) Claire M. Erickson et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Family members' perspectives on learning cognitively unimpaired older adults' amyloid‐β PET scan results
- (2021) Emily A. Largent et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Alzheimer's disease biomarkers in Black and non‐Hispanic White cohorts: A contextualized review of the evidence
- (2021) Carey E. Gleason et al. Alzheimers & Dementia
- The relative contributions of biomarkers, disease modifying treatment, and dementia severity to Alzheimer's stigma: A vignette-based experiment
- (2021) Shana D. Stites et al. SOCIAL SCIENCE & MEDICINE
- Disclosure of Amyloid Status for Risk of Alzheimer Disease to Cognitively Normal Research Participants With Subjective Cognitive Decline: A Longitudinal Study
- (2020) Taisei Wake et al. American Journal of Alzheimers Disease and Other Dementias
- Cognitively unimpaired adults’ reactions to disclosure of amyloid PET scan results
- (2020) Emily A. Largent et al. PLoS One
- Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals
- (2020) Reisa A. Sperling et al. JAMA Neurology
- Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval
- (2020) Martin Tolar et al. Alzheimers Research & Therapy
- Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment
- (2020) Joshua D. Grill et al. JAMA Neurology
- Communicating 5-Year Risk of Alzheimer’s Disease Dementia: Development and Evaluation of Materials that Incorporate Multiple Genetic and Biomarker Research Results
- (2020) Jessica Mozersky et al. JOURNAL OF ALZHEIMERS DISEASE
- Biomarkers for Alzheimer Dementia in Diverse Racial and Ethnic Minorities—A Public Health Priority
- (2019) Lisa L. Barnes JAMA Neurology
- Huntington's disease in the United States: Variation by demographic and socioeconomic factors
- (2019) Emilie Bruzelius et al. MOVEMENT DISORDERS
- The National Institute on Minority Health and Health Disparities Research Framework
- (2019) Jennifer Alvidrez et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Patient Stakeholder Versus Physician Preferences Regarding Amyloid PET Testing
- (2019) Melissa J. Armstrong et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Confidential genetic testing and electronic health records: A survey of current practices among Huntington disease testing centers
- (2019) Celeste C. Eno et al. Molecular Genetics & Genomic Medicine
- Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies
- (2019) Jie Ding et al. LANCET NEUROLOGY
- Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease
- (2018) Ron Brookmeyer et al. Alzheimers & Dementia
- Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States
- (2018) Ron Brookmeyer et al. Alzheimers & Dementia
- What features of stigma do the public most commonly attribute to Alzheimer's disease dementia? Results of a survey of the U.S. general public
- (2018) Shana D. Stites et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Prediction and Early Detection of Alzheimer’s Dementia: Professional Disclosure Practices and Ethical Attitudes
- (2018) Mark Schweda et al. JOURNAL OF ALZHEIMERS DISEASE
- Perspectives on Communicating Biomarker-Based Assessments of Alzheimer’s Disease to Cognitively Healthy Individuals
- (2018) Richard Milne et al. JOURNAL OF ALZHEIMERS DISEASE
- Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older Adults
- (2018) Jessica Mozersky et al. JAMA Neurology
- On the personal utility of Alzheimer’s disease-related biomarker testing in the research context
- (2018) Eline M Bunnik et al. JOURNAL OF MEDICAL ETHICS
- Huntington disease: A quarter century of progress since the gene discovery
- (2018) Claudia M. Testa et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review
- (2018) Arno de Wilde et al. Alzheimers Research & Therapy
- Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need
- (2018) Ganesh M. Babulal et al. Alzheimers & Dementia
- Ethical Arguments Concerning the Use of Alzheimer’s Disease Biomarkers in Individuals with No or Mild Cognitive Impairment: A Systematic Review and Framework for Discussion
- (2018) Marthe Smedinga et al. JOURNAL OF ALZHEIMERS DISEASE
- Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
- (2018) Harald Hampel et al. Nature Reviews Neurology
- Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability
- (2016) Yen Ying Lim et al. Alzheimers & Dementia
- Genetic counseling and testing for Huntington's disease: A historical review
- (2016) Martha A. Nance AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials
- (2016) Joshua D. Grill et al. NEUROBIOLOGY OF AGING
- Desire for predictive testing for Alzheimer’s disease and impact on advance care planning: a cross-sectional study
- (2016) Meera Sheffrin et al. Alzheimers Research & Therapy
- Legal consequences and protections: Challenges for documenting preclinical biomarkers in patients' medical records
- (2015) Jalayne J. Arias et al. Alzheimers & Dementia
- Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants
- (2015) Kristin Harkins et al. Alzheimers Research & Therapy
- Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results
- (2015) Jonathan Gooblar et al. JAMA Neurology
- Public Perceptions of Presymptomatic Testing for Alzheimer Disease
- (2014) Richard J. Caselli et al. MAYO CLINIC PROCEEDINGS
- Effect of Knowledge of APOE Genotype on Subjective and Objective Memory Performance in Healthy Older Adults
- (2013) Tara T. Lineweaver et al. AMERICAN JOURNAL OF PSYCHIATRY
- Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
- (2013) K. A. Johnson et al. JOURNAL OF NUCLEAR MEDICINE
- Using AD biomarker research results for clinical care: A survey of ADNI investigators
- (2013) M. B. Shulman et al. NEUROLOGY
- Estimating and communicating prognosis in advanced neurologic disease
- (2013) R. G. Holloway et al. NEUROLOGY
- Would you want to know? Public attitudes on early diagnostic testing for Alzheimer's disease
- (2013) Elizabeth M Wikler et al. Alzheimers Research & Therapy
- Recommendations for the predictive genetic test in Huntington's disease
- (2012) R MacLeod et al. CLINICAL GENETICS
- Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease
- (2012) J. Scott Roberts et al. GENETICS IN MEDICINE
- Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease
- (2011) J. Karlawish NEUROLOGY
- Informed choice in direct-to-consumer genetic testing for Alzheimer and other diseases: lessons from two cases
- (2011) Donna A. Messner NEW GENETICS AND SOCIETY
- How do we achieve informed choice for women considering breast screening?
- (2011) Jolyn Hersch et al. PREVENTIVE MEDICINE
- A Systematic Review and Meta-Analysis of Ethnic Differences in Use of Dementia Treatment, Care, and Research
- (2010) Claudia Cooper et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Dementia care in rural and remote settings: A systematic review of informal/family caregiving
- (2010) Anthea Innes et al. MATURITAS
- Disclosure ofAPOEGenotype for Risk of Alzheimer's Disease
- (2009) Robert C. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now